Enanta Pharmaceuticals Inc (ENTA) — Capital Reinvestment Ratio
Enanta Pharmaceuticals Inc (ENTA) has a Capital Reinvestment Ratio of 0.01x as of June 2025, meaning it reinvests 0% of its operating cash flow ($17.51 Million) in capital expenditures ($155.00K). Check tangible equity quality of Enanta Pharmaceuticals Inc to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Enanta Pharmaceuticals Inc Capital Reinvestment Ratio (2011–2020)
This chart tracks Enanta Pharmaceuticals Inc's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see Enanta Pharmaceuticals Inc cash conversion from operations.
Annual Capital Reinvestment Ratio for Enanta Pharmaceuticals Inc (2011–2020)
Year-by-year Capital Reinvestment Ratio for Enanta Pharmaceuticals Inc from 2011 to 2020. See cash generation quality of Enanta Pharmaceuticals Inc to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.20x | $7.09 Million | $1.45 Million | ▲ +168.8% |
| 2019 | 0.08x | $71.42 Million | $5.42 Million | ▼ -25.7% |
| 2018 | 0.10x | $29.22 Million | $2.98 Million | ▲ +114.4% |
| 2017 | 0.05x | $52.65 Million | $2.51 Million | ▼ -64.0% |
| 2016 | 0.13x | $35.81 Million | $4.74 Million | ▲ +334.3% |
| 2015 | 0.03x | $76.67 Million | $2.34 Million | ▼ -40.2% |
| 2014 | 0.05x | $20.18 Million | $1.03 Million | ▼ -10.4% |
| 2013 | 0.06x | $10.65 Million | $606.00K | ▲ +410.7% |
| 2012 | 0.01x | $22.62 Million | $252.00K | ▼ -39.9% |
| 2011 | 0.02x | $24.02 Million | $445.00K | — |